FA
ZURA icon

Forefront Analytics’s Zura Bio ZURA Stock Holding History

Forefront Analytics’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$88.7K Sell
14,901
-4,676
-24% -$28.2K 0.08% 34
2025
Q4 		$103K Sell
19,577
-1,941
-9% -$7.67K 0.09% 37
2025
Q3 		$93.2K Sell
21,518
-42,467
-66% -$76.4K 0.09% 38
2025
Q2 		$67.2K Sell
63,985
-44,323
-41% -$53K 0.08% 38
2025
Q1 		$140K Buy
108,308
+54,574
+102% +$86.1K 0.16% 37
2024
Q4 		$134K Buy
53,734
+22,924
+74% +$81.7K 0.06% 55
2024
Q3 		$125K Sell
30,810
-10,759
-26% -$40.2K 0.06% 60
2024
Q2 		$145K Buy
41,569
+7,531
+22% +$30.7K 0.07% 58
2024
Q1 		$87.5K Buy
34,038
+12,809
+60% +$45.4K 0.04% 63
2023
Q4 		$99.1K Buy
21,229
+6,765
+47% +$33.8K 0.05% 60
2023
Q3 		$95.5K Buy
+14,464
New +$96.7K 0.05% 54

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Forefront Analytics's ZURA Position: Q1 2026 in Review

Forefront Analytics reduced its Zura Bio (ZURA) stake by 24% in Q1 2026, selling an estimated $28.2K and leaving 14,901 shares worth $88.7K. The position accounts for 0.08% of the portfolio, ranked #34.

Forefront Analytics first reported a position in ZURA in Q3 2023 and has held it in 11 quarters since. The position peaked at $145K in Q2 2024. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • Forefront Analytics held 14,901 shares of Zura Bio worth $88.7K as of Q1 2026.
  • Forefront Analytics sold 4,676 Zura Bio shares in Q1 2026, an estimated $28.2K.
  • Zura Bio made up 0.08% of Forefront Analytics's portfolio in Q1 2026, its #34 holding.
  • Forefront Analytics first reported a position in Zura Bio in Q3 2023 and has held it in 11 quarters since.
  • Forefront Analytics's Zura Bio position peaked at $145K in Q2 2024.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Forefront Analytics's 13F filing for Q1 2026, filed 13 May 2026.